9 results on '"Ke-Yong Wang"'
Search Results
2. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
- Author
-
Takashi Kido, Hirotsugu Noguchi, Sohsuke Yamada, Keishi Oda, Tetsuya Hanaka, Ke-Yong Wang, Hiroshi Mukae, Hiroshi Ishimoto, Hiroto Izumi, Xin Guo, Aya Nawata, Shingo Noguchi, Kazuhiro Yatera, and Tsutomu Takaki
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Exacerbation ,Idiopathic pulmonary fibrosis ,Bleomycin ,Peroxiredoxin 4 ,Gastroenterology ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Fibrosis ,Lactate dehydrogenase ,Internal medicine ,Pulmonary fibrosis ,medicine ,Animals ,Humans ,Aged ,Retrospective Studies ,030304 developmental biology ,lcsh:RC705-779 ,0303 health sciences ,Lung ,business.industry ,Surfactant protein D ,lcsh:Diseases of the respiratory system ,Peroxiredoxins ,Middle Aged ,respiratory system ,medicine.disease ,humanities ,respiratory tract diseases ,Disease Models, Animal ,Acute exacerbation ,medicine.anatomical_structure ,030228 respiratory system ,chemistry ,Disease Progression ,Female ,business ,Biomarkers ,Research Article - Abstract
Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is life-threatening. Several serum biomarkers, such as Krebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D), are clinically used for evaluating AE-IPF, but these biomarkers are not adequate for establishing an early and accurate diagnosis of AE-IPF. Recently, the protective roles of the members of the peroxiredoxin (PRDX) family have been reported in IPF; however, the role of PRDX4 in AE-IPF is unclear. Methods Serum levels of PRDX4 protein, KL-6, SP-D and lactate dehydrogenase (LDH) in 51 patients with stable IPF (S-IPF), 38 patients with AE-IPF and 15 healthy volunteers were retrospectively assessed using enzyme-linked immunosorbent assay. Moreover, as an animal model of pulmonary fibrosis, wild-type (WT) and PRDX4-transgenic (Tg) mice were intratracheally administered with bleomycin (BLM, 2 mg/kg), and fibrotic and inflammatory changes in lungs were evaluated 3 weeks after the intratracheal administration. Results Serum levels of PRDX4 protein, KL-6, SP-D and LDH in patients with S-IPF and AE-IPF were significantly higher than those in healthy volunteers, and those in AE-IPF patients were the highest among the three groups. Using receiver operating characteristic curves, area under the curve values of serum PRDX4 protein, KL-6, SP-D, and LDH for detecting AE-IPF were 0.873, 0.698, 0.675, and 0.906, respectively. BLM-treated Tg mice demonstrated aggravated histopathological findings and poor prognosis compared with BLM-treated WT mice. Moreover, PRDX4 expression was observed in alveolar macrophages and lung epithelial cells of BLM-treated Tg mice. Conclusions PRDX4 is associated with the aggravation of inflammatory changes and fibrosis in the pathogenesis of IPF, and serum PRDX4 may be useful in clinical practice of IPF patients.
- Published
- 2019
3. Usefulness of myeloperoxidase as a biomarker for the ranking of pulmonary toxicity of nanomaterials
- Author
-
Chinatsu Nishida, Shingo Noguchi, Hiroto Izumi, Takashi Marui, Takami Okada, Masaru Kubo, Ke-Yong Wang, Manabu Shimada, Takako Oyabu, Toshihiko Myojo, Yasuo Morimoto, Byeong-Woo Lee, Taisuke Tomonaga, Yukiko Yoshiura, and Kazuhiro Yatera
- Subjects
Male ,0301 basic medicine ,Neutrophils ,Pulmonary toxicity ,Health, Toxicology and Mutagenesis ,lcsh:Industrial hygiene. Industrial welfare ,010501 environmental sciences ,Pharmacology ,Toxicology ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,lcsh:RA1190-1270 ,Lactate dehydrogenase ,Macrophages, Alveolar ,medicine ,Animals ,Lung ,Peroxidase ,lcsh:Toxicology. Poisons ,0105 earth and related environmental sciences ,Inhalation exposure ,Inhalation Exposure ,Myeloperoxidase ,Inhalation ,medicine.diagnostic_test ,biology ,Research ,Biomarker ,General Medicine ,Nanomaterial ,Rats, Inbred F344 ,Heme oxygenase ,030104 developmental biology ,Bronchoalveolar lavage ,chemistry ,Toxicity ,biology.protein ,Rat ,Nanoparticles ,Chemokines ,Bronchoalveolar Lavage Fluid ,Intratracheal instillation ,Biomarkers ,lcsh:HD7260-7780.8 - Abstract
Background In order to examine whether myeloperoxidase (MPO) can be a useful marker for evaluating the pulmonary toxicity of nanomaterials, we analyzed MPO protein in bronchoalveolar lavage fluid (BALF) samples obtained from previous examinations of a rat model. In those examinations we performed intratracheal instillation exposures (dose: 0.2–1.0 mg) and inhalation exposures (exposure concentration: 0.32–10.4 mg/m3) using 9 and 4 nanomaterials with different toxicities, respectively. Based on those previous studies, we set Nickel oxide nanoparticles (NiO), cerium dioxide nanoparticles (CeO2), multi wall carbon nanotubes with short or long length (MWCNT (S) and MWCNT (L)), and single wall carbon nanotube (SWCNT) as chemicals with high toxicity; and titanium dioxide nanoparticles (TiO2 (P90) and TiO2 (Rutile)), zinc oxide nanoparticles (ZnO), and toner with external additives including nanoparticles as chemicals with low toxicity. We measured the concentration of MPO in BALF samples from rats from 3 days to 6 months following a single intratracheal instillation, and from 3 days to 3 months after the end of inhalation exposure. Results Intratracheal instillation of high toxicity NiO, CeO2, MWCNT (S), MWCNT (L), and SWCNT persistently increased the concentration of MPO, and inhalation of NiO and CeO2 increased the MPO in BALF. By contrast, intratracheal instillation of low toxicity TiO2 (P90), TiO2 (Rutile), ZnO, and toner increased the concentration of MPO in BALF only transiently, and inhalation of TiO2 (Rutile) and ZnO induced almost no increase of the MPO. The concentration of MPO correlated with the number of total cells and neutrophils, the concentration of chemokines for neutrophils (cytokine-induced neutrophil chemoattractant (CINC)-1 and heme oxygenase (HO)-1), and the activity of released lactate dehydrogenase (LDH) in BALF. The results from the receiver operating characteristics (ROC) for the toxicity of chemicals by the concentration of MPO proteins in the intratracheal instillation and inhalation exposures showed that the largest areas under the curves (AUC) s in both examinations occurred at 1 month after exposure. Conclusion These data suggest that MPO can be a useful biomarker for the ranking of the pulmonary toxicity of nanomaterials, especially at 1 month after exposure, in both intratracheal instillation and inhalation exposure. Electronic supplementary material The online version of this article (10.1186/s12989-018-0277-x) contains supplementary material, which is available to authorized users.
- Published
- 2018
4. Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
- Author
-
Ke-Yong Wang, Yasuyuki Sasaguri, Inenaga S, Hiroto Izumi, Toshihiro Imamura, Shohei Shimajiri, Kimitoshi Kohno, Li Z, Ying Wu, Sohsuke Yamada, and Nakano R
- Subjects
Adult ,Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,Pancreatic disease ,pancreatic cancer ,Polypeptide N-acetylgalactosaminyltransferase ,Biology ,Metastasis ,Cell Line, Tumor ,Internal medicine ,Pancreatic cancer ,parasitic diseases ,medicine ,metastasis ,Humans ,Clinical significance ,Molecular Diagnostics ,Pathological ,Aged ,Cancer ,Middle Aged ,Prognosis ,medicine.disease ,Immunohistochemistry ,Pancreatic Neoplasms ,carbohydrates (lipids) ,GalNAc-T6 ,N-Acetylgalactosaminyltransferases ,GalNAc-T3 ,Female ,lipids (amino acids, peptides, and proteins) - Abstract
Background: The family of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) is responsible for the altered glycosylation in cancer. The purpose of our study was to investigate the clinical significance of two isoforms, GalNAc-T6 and -T3, and their correlation with the prognosis of pancreatic cancer. Methods: Immunohistochemistry was used to analyse GalNAc-T6 and -T3 expressions in 70 clinicopathologically characterised pancreatic cancer cases. Results: Positive expressions of GalNAc-T6 and -T3 were immunohistochemically identified in 51% (36 of 70) and in 77% (54 of 70) of patients, respectively. A close relationship was noted between GalNAc-T6 positive expression and pathological well/moderate differentiated type (P=0.001), small tumour size (P=0.044), absence of vascular invasion (P=0.009), and low stage of the American Joint Committee on Cancer systems (P=0.043). The expression of GalNAc-T3 significantly correlated with good differentiation (P=0.001), but not with other clinicopathologic features. Furthermore, univariate and multivariate analyses revealed that GalNAc-T6 expression was an independent prognosis indicator for the disease, whereas GalNAc-T3 expression had no impact on clinical outcome, even though 33 of 36 GalNAc-T6-positive cases also had a positive expression of GalNAc-T3 (P=0.001, r=0.356). Conclusion: Both GalNAc-T6 and -T3 expressions correlated significantly with tumour differentiation, whereas only GalNAc-T6 expression predicted prognosis in pancreatic cancer.
- Published
- 2011
5. Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction
- Author
-
Ke-Yong Wang, Yun-peng Liu, Yoshifumi Nakayama, Hiroto Izumi, Ken-ichi Ito, Hidetaka Uramoto, Kimitoshi Kohno, Zhi Li, and Ying Wu
- Subjects
Cancer Research ,Y-box binding protein 1 ,Down-Regulation ,Eukaryotic DNA replication ,Protein interaction domains and motifs ,Topoisomerase-I Inhibitor ,Transfection ,Antioxidants ,Catalysis ,chemistry.chemical_compound ,Cell Line, Tumor ,medicine ,Topoisomerase 1 ,Humans ,Protein–DNA interaction ,Binding Sites ,biology ,Research ,Topoisomerase ,Y box binding protein 1 ,Acetylcysteine ,Enzyme Activation ,Gene Expression Regulation, Neoplastic ,Oxidative Stress ,DNA Topoisomerases, Type I ,Oncology ,chemistry ,Biochemistry ,Drug Resistance, Neoplasm ,Drug resistance ,biology.protein ,Nucleic Acid Conformation ,Camptothecin ,RNA Interference ,Y-Box-Binding Protein 1 ,Topoisomerase I Inhibitors ,DNA ,Protein Binding ,medicine.drug - Abstract
Background The Y-box binding protein 1 (YB-1) possesses pleiotropic functions through its interactions with various cellular proteins, and its high expression levels make it a potential useful prognostic biomarker for cancer cells. Eukaryotic DNA topoisomerases, such as DNA topoisomerase 1 (TOPO1) and DNA topoisomerase 2 (TOPO2), are the essential DNA metabolism regulators that usually overexpressed in cancer cells, and multiple proteins have been reported to regulate the enzyme activity and the clinical efficacy of their inhibitors. The present study unraveled the interaction of YB-1 with TOPO1, and further investigated the related function and potential mechanisms during the interaction. Methods The direct association of TOPO1 with specific domain of YB-1 was explored by co-immunoprecipitation and GST pull-down assays. The interaction function was further clarified by DNA relaxation assays, co-immunoprecipitation and WST-8 assays with in vitro gain- and loss- of function models. Results We found that YB-1 interacts directly with TOPO1 (but not with TOPO2) and promotes TOPO1 catalytic activity. Interactions between YB-1 and TOPO1 increased when cancer cells were treated with the TOPO1 inhibitor, camptothecin (CPT), but not with the TOPO2 inhibitor, adriamycin (ADM). Furthermore, we found that the interaction is prevented by pretreatment with the antioxidant agent, N-acetyl cysteine, and that YB-1 downregulation renders cells resistant to CPT. Conclusions Our findings suggest that nuclear YB-1 serves as an intracellular promoter of TOPO1 catalytic activity that enhances CPT sensitivity through its direct interaction with TOPO1.
- Published
- 2014
6. Erratum to: Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma
- Author
-
Yoshikazu Harada, Hiroto Izumi, Hirotsugu Noguchi, Akihiro Kuma, Yuichiro Kawatsu, Tomoko Kimura, Shohei Kitada, Hidetaka Uramoto, Ke-Yong Wang, Yasuyuki Sasaguri, Hiroshi Hijioka, Akihiko Miyawaki, Ryoichi Oya, Toshiyuki Nakayama, Kimitoshi Kohno, and Sohsuke Yamada
- Subjects
General Medicine - Published
- 2015
7. Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice
- Author
-
Ke-Yong Wang, Yumiko Toyohira, Nobuyuki Yanagihara, Kazuhiro Yatera, Toshinori Kawanami, Kei Yamasaki, Hiroshi Ishimoto, Shingo Noguchi, Hiroaki Shimokawa, Kentarou Akata, Masato Tsutsui, Hiroshi Mukae, and Keishi Oda
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Pathology ,medicine.medical_specialty ,Pulmonary Fibrosis ,Pharmacology ,Nitric Oxide ,Bleomycin ,Nitric oxide ,Pathogenesis ,Mice ,chemistry.chemical_compound ,Pulmonary fibrosis ,medicine ,Animals ,Mice, Knockout ,Lung ,biology ,medicine.diagnostic_test ,business.industry ,Research ,medicine.disease ,Nitric oxide synthase ,medicine.anatomical_structure ,Bronchoalveolar lavage ,chemistry ,biology.protein ,Isosorbide dinitrate ,business ,medicine.drug - Abstract
Background Increased expression of nitric oxide synthase (NOS) and an increase in plasma nitrite plus nitrate (NOx) have been reported in patients with pulmonary fibrosis, suggesting that nitric oxide (NO) plays an important role in its development. However, the roles of the entire NO and NOS system in the pathogenesis of pulmonary fibrosis still remain to be fully elucidated. The aim of the present study is to clarify the roles of NO and the NOS system in pulmonary fibrosis by using the mice lacking all three NOS isoforms. Methods Wild-type, single NOS knockout and triple NOS knockout (n/i/eNOS−/−) mice were administered bleomycin (BLM) intraperitoneally at a dose of 8.0 mg/kg/day for 10 consecutive days. Two weeks after the end of the procedure, the fibrotic and inflammatory changes of the lung were evaluated. In addition, we evaluated the effects of long-term treatment with isosorbide dinitrate, a NO donor, on the n/i/eNOS−/− mice with BLM-induced pulmonary fibrosis. Results The histopathological findings, collagen content and the total cell number in bronchoalveolar lavage fluid were the most severe/highest in the n/i/eNOS−/− mice. Long-term treatment with the supplemental NO donor in n/i/eNOS−/− mice significantly prevented the progression of the histopathological findings and the increase of the collagen content in the lungs. Conclusions These results provide the first direct evidence that a lack of all three NOS isoforms led to a deterioration of pulmonary fibrosis in a BLM-treated murine model. We speculate that the entire endogenous NO and NOS system plays an important protective role in the pathogenesis of pulmonary fibrosis.
- Published
- 2014
8. Pleomorphic carcinoma of the breast associated with cyst formation: a unique surgical case focusing on cytological and immunohistochemical findings. Cystic breast PC
- Author
-
Atsunori Nabeshima, Ke-Yong Wang, Satoshi Kimura, Yoshika Nagata, Yasuyuki Sasaguri, Shohei Kitada, Shohei Shimajiri, Sohsuke Yamada, Hirotsugu Noguchi, and Takashi Tasaki
- Subjects
Pathology ,medicine.medical_specialty ,Histology ,Biopsy, Fine-Needle ,Case Report ,Breast Neoplasms ,Biology ,Mastectomy, Segmental ,Malignancy ,Pathology and Forensic Medicine ,Stromal Invasion ,Gross examination ,Lesion ,Cytology ,Biopsy ,Biomarkers, Tumor ,medicine ,Humans ,Cyst ,Breast ,medicine.diagnostic_test ,Cysts ,Epithelial Cells ,General Medicine ,Anatomy ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Plemorphic carcinoma ,Giant cell ,Female ,medicine.symptom - Abstract
A mammary nodular lesion was recognized one month before the surgery in the right upper breast of a 55-year-old female. The fine needle aspiration cytology specimens contained many individual bizarre, multi-nucleated, and/or giant cells having hyperchromatic pleomorphic nuclei, prominent nucleoli, and relatively abundant cytoplasm, admixed with numerous mitotic figures in a hemorrhagic or inflammatory background. A small amount of sheet-like or three-dimensional clusters of malignant cells coexisted. We first interpreted it as high-grade malignancy, such as invasive carcinoma, not otherwise specified. A right breast-conserving surgery was performed, and gross examination revealed a cystic cavity-formed and solid tumor lesion, measuring 35 × 35 × 25 mm and looking gray-yellowish to -whitish. On microscopic examination, the tumor was composed of a diffuse proliferation of highly atypical cells devoid of adhesive characteristics, including many multi-nucleated giant bizarre cells, in a haphazard fashion with stromal invasion, alternating with sarcomatoid features of spindle tumor cells. The cystic cavity was surrounded by hemorrhagic and inflammatory granulation tissue and lined by mostly denuded but atypical tumor cells or bland-looking flattened epithelial cells. Immunohistochemically, these tumor cells are specifically positive for all epithelial markers. Therefore, we made a conclusive diagnosis of pleomorphic carcinoma of the breast with cyst formation. We should be aware that, owing to its characteristic findings, cytopathologists can diagnose correctly, based on careful cytological examination of adequate samplings. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9290689448998782
- Published
- 2013
9. Diffuse large B-cell lymphoma presenting with neurolymphomatosis and intravascular lymphoma: a unique autopsy case with diverse neurological symptoms
- Author
-
Takashi Tasaki, Hirotsugu Noguchi, Shohei Kitada, Sohsuke Yamada, Akihide Tanimoto, Ke Yong Wang, Atsunori Nabeshima, and Yasuyuki Sasaguri
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Histology ,Nerve root ,Case Report ,Autopsy ,Adenocarcinoma ,Pathology and Forensic Medicine ,Mononeuropathy ,Fatal Outcome ,Peripheral nerve ,Stomach Neoplasms ,Intravascular lymphoma (IVL) ,lcsh:Pathology ,Diabetes Mellitus ,medicine ,Humans ,Diffuse large B-cell lymphoma (DLBL) ,Aged ,Neurolymphomatosis (NL) ,Palsy ,business.industry ,Peripheral Nervous System Diseases ,Neoplasms, Second Primary ,General Medicine ,medicine.disease ,Vascular Neoplasms ,Lymphoma ,Lymphoma, Large B-Cell, Diffuse ,business ,Diffuse large B-cell lymphoma ,lcsh:RB1-214 ,Cancer of unknown primary origin - Abstract
A 78-year-old Japanese male noticed a difficulty in the beginning of standing up, followed by 7a progressive numbness of extremities with pain, Bell’s palsy, dysarthria, and difficulty in swallowing. A clinician had suspected cancer of unknown primary origin, accompanied by the diverse and elusive neurological symptoms, likely presenting as painful mononeuropathy simplex and cranial neuropathy. He developed dysbasia over weeks and died 1 month after the symptom onset. At autopsy, an ill-defined large and soft tumor mass in the right lobe of the liver with direct invasion into the right adrenal gland was observed. The left adrenal gland or right iliopsoas muscle was also involved. Microscopic findings showed a monotonous proliferation of medium-sized to large atypical lymphoid cells, which were diffusely positive for CD20 in immunohistochemistry, consistent with diffuse large B-cell lymphoma (DLBL). Furthermore, the lymphoma cells aggressively infiltrated endoneurial and subperineurial spaces not only in the peripheral nerves and plexuses, but partly in the spinal nerve roots, and intravascular spaces in various tissues. Therefore, systemic lymphoma (DLBL) complicated with neurolymphomatosis (NL) and intravascular lymphoma (IVL) was diagnosed. Very early diagnosis and treatment are necessary for the NL patients with poor prognosis. Virtual slides The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5862472377020448.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.